Investor Alert

New York Markets Open in:

Gilead Sciences Inc.



Before the Bell

 --Quotes are delayed by 20 min

May 19, 2022, 6:46 a.m.





-0.02 -0.05%


Volume 619

Quotes are delayed by 20 min


Previous close

$ 63.22

$ 63.22


+0.04 +0.06%

Day low

Day high




52 week low

52 week high




Annual Financials for Gilead Sciences Inc.


Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Cash & Short Term Investments 26.15B30.95B24.67B8.26B7.41B
Cash Only 7.59B17.94B11.63B6B5.34B
Short-Term Investments 18.56B13.01B13.04B2.26B2.07B
Total Accounts Receivable 3.85B3.33B3.58B4.9B4.49B
Accounts Receivables, Net 3.85B3.33B3.58B4.89B4.49B
Accounts Receivables, Gross 4.31B3.91B4.34B4.94B4.54B
Bad Debt/Doubtful Accounts (455M)(583M)(758M)(44M)(47M)
Other Receivables ---9M-
Inventories 801M814M922M1.68B1.62B
Finished Goods -----
Work in Progress -----
Raw Materials -----
Progress Payments & Other -----
Other Current Assets 1.03B743M1.12B1.15B1.26B
Miscellaneous Current Assets 1.03B743M1.12B1.15B1.26B
Total Current Assets 31.82B35.84B30.3B16B14.77B
20172018201920202021 5-year trend
Net Property, Plant & Equipment 3.3B4.01B5.17B5.61B5.66B
Property, Plant & Equipment - Gross 4.29B5.2B6.59B7.28B7.56B
Buildings 2.18B2.34B3.36B3.68B3.79B
Land & Improvements 396M404M404M404M404M
Computer Software and Equipment -----
Other Property, Plant & Equipment 494M558M634M793M807M
Accumulated Depreciation 994M1.19B1.42B1.67B1.89B
Total Investments and Advances 11.18B1.57B1.66B2.26B2.51B
Other Long-Term Investments 11.18B1.57B1.66B2.26B2.51B
Long-Term Note Receivable -----
Intangible Assets 21.26B19.86B17.9B41.23B41.79B
Net Goodwill 4.16B4.12B4.12B8.11B8.33B
Net Other Intangibles 17.1B15.74B13.79B33.13B-
Other Assets 2.7B2.41B6.6B3.31B3.22B
Tangible Other Assets 2.7B2.41B6.6B3.31B3.22B
Total Assets 70.28B63.68B61.63B68.41B67.95B

Liabilities & Shareholders' Equity

20172018201920202021 5-year trend
ST Debt & Current Portion LT Debt 2.75B2.75B2.6B2.86B1.62B
Short Term Debt --99M107M-
Current Portion of Long Term Debt 2.75B2.75B2.5B2.76B1.52B
Accounts Payable 814M790M713M844M705M
Income Tax Payable 713M190M287M598M539M
Other Current Liabilities 7.36B6.88B6.16B7.09B8.75B
Dividends Payable -----
Accrued Payroll 455M555M599M864M927M
Miscellaneous Current Liabilities 6.91B6.32B5.56B6.23B7.82B
Total Current Liabilities 11.64B10.61B9.76B11.4B11.61B
Long-Term Debt 30.8B24.57B22.72B29.25B25.67B
Long-Term Debt excl. Capitalized Leases 30.8B24.57B22.09B28.65B25.18B
Non-Convertible Debt 30.8B24.57B22.09B28.65B25.18B
Convertible Debt -----
Capitalized Lease Obligations -----
Provision for Risks & Charges -----
Deferred Taxes (27M)---4.36B
Deferred Taxes - Credit ----4.36B
Deferred Taxes - Debit 27M----
Other Liabilities 7.35B6.96B6.5B9.54B5.25B
Other Liabilities (excl. Deferred Income) 7.35B6.96B6.5B9.54B5.25B
Deferred Income -----
Total Liabilities 49.78B42.14B38.98B50.19B46.89B
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 20.44B21.39B22.53B18.2B21.07B
Common Stock Par/Carry Value 1M1M1M1M1M
Retained Earnings 19.01B19.02B19.39B14.38B16.32B
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain 85M47M53M51M13M
Unrealized Gain/Loss Marketable Securities 194M(52M)1M2M(4M)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 20.44B21.39B22.53B18.2B21.07B
Accumulated Minority Interest 59M147M125M19M(5M)
Total Equity 20.5B21.53B22.65B18.22B21.06B
Liabilities & Shareholders' Equity 70.28B63.68B61.63B68.41B67.95B
Link to MarketWatch's Slice.